{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:15:13Z","timestamp":1778894113633,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ekir.2025.01.038","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T19:15:31Z","timestamp":1738610131000},"page":"1143-1151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Pan-Inhibitor of Phosphate Transporters AP306 in Hemodialysis Patients"],"prefix":"10.1016","volume":"10","author":[{"given":"Li","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leyi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunling","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menghua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongli","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guisen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weifeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingxue Cathy","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2025.01.038_bib1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2025.01.038_bib2","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1053\/j.ajkd.2010.02.340","article-title":"KDOQI US commentary on the 2009 KDIGO clinical practice guideline for the diagnosis, evaluation, and treatment of CKD\u2013Mineral and Bone Disorder (CKD-MBD)","volume":"55","author":"Uhlig","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2025.01.038_bib3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1681\/ASN.2008040349","article-title":"Association of serum phosphate with vascular and valvular calcification in moderate CKD","volume":"20","author":"Adeney","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2025.01.038_bib4","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2025.01.038_bib5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/ndt\/gfv055","article-title":"The challenge of controlling phosphorus in chronic kidney disease","volume":"31","author":"Cannata-And\u00eda","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"113","key":"10.1016\/j.ekir.2025.01.038_bib6","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic KidneyDisease-Mineral and Bone Disorder (CKD-MBD)","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ekir.2025.01.038_bib7","first-page":"1","article-title":"KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease\u2013Mineral and Bone Disorder (CKD-MBD)","volume":"7","year":"2017","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ekir.2025.01.038_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2022.100584","article-title":"Serum phosphorus level rises in US hemodialysis patients over the past decade: A DOPPS special report","volume":"5","author":"Guedes","year":"2023","journal-title":"Kidney Med"},{"key":"10.1016\/j.ekir.2025.01.038_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam6474","article-title":"Inhibition of sodium\/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeability","volume":"10","author":"King","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ekir.2025.01.038_bib10","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1681\/ASN.2018080832","article-title":"Efficacy and safety of tenapanor in patients with hyperphosphatemia receiving maintenance hemodialysis: A randomized Phase 3 trial","volume":"30","author":"Block","year":"2019","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2025.01.038_bib11","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.34067\/KID.0002002021","article-title":"Safety and efficacy of tenapanor for long-term serum phosphate control in maintenance dialysis: A 52-week randomized Phase 3 trial (PHREEDOM)","volume":"2","author":"Block","year":"2021","journal-title":"Kidney360"},{"key":"10.1016\/j.ekir.2025.01.038_bib12","doi-asserted-by":"crossref","first-page":"732","DOI":"10.34067\/KID.0000000000000387","article-title":"Tenapanor as therapy for hyperphosphatemia in maintenance dialysis patients: Results from the OPTIMIZE study","volume":"5","author":"Sprague","year":"2024","journal-title":"Kidney360"},{"key":"10.1016\/j.ekir.2025.01.038_bib13","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1681\/ASN.2011121213","article-title":"Npt2b deletion attenuates hyperphosphatemia associated with CKD","volume":"23","author":"Schiavi","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2025.01.038_bib14","doi-asserted-by":"crossref","first-page":"F1466","DOI":"10.1152\/ajprenal.00279.2009","article-title":"Regulation of rat intestinal Na-dependent phosphate transporters by dietary phosphate","volume":"297","author":"Giral","year":"2009","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.ekir.2025.01.038_bib15","doi-asserted-by":"crossref","first-page":"F285","DOI":"10.1152\/ajprenal.00508.2009","article-title":"Phosphate homeostasis and the renal-gastrointestinal axis","volume":"299","author":"Marks","year":"2010","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.ekir.2025.01.038_bib16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.kint.2020.02.040","article-title":"EOS789, a novel pan-phosphate transporter inhibitor, is effective for the treatment of chronic kidney disease\u2013mineral bone disorder","volume":"98","author":"Tsuboi","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2025.01.038_bib17","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.kint.2020.09.035","article-title":"EOS789, a broad-spectrum inhibitor of phosphate transport, is safe with an indication of efficacy in a phase 1b randomized crossover trial in hemodialysis patients","volume":"99","author":"Hill Gallant","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2025.01.038_bib18","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1681\/ASN.V451205","article-title":"Second generation logarithmic estimates of single-pool variable volume Kt\/V: An analysis of error","volume":"4","author":"Daugirdas","year":"1993","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4 suppl 3","key":"10.1016\/j.ekir.2025.01.038_bib19","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2025.01.038_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ekir.2017.08.003","article-title":"NPT-IIb inhibition does not improve hyperphosphatemia in CKD","volume":"3","author":"Larsson","year":"2018","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2025.01.038_bib21","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ekir.2020.12.017","article-title":"NaPi-IIb inhibition for hyperphosphatemia in CKD hemodialysis patients","volume":"6","author":"Maruyama","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2025.01.038_bib22","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/ndt\/gfw042","article-title":"Efficacy and safety of nicotinamide in haemodialysis patients: The NICOREN study","volume":"32","author":"Lenglet","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2025.01.038_bib23","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients","volume":"70","author":"Kalantar-Zadeh","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2025.01.038_bib24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0272-6386(03)00554-7","article-title":"Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: A new phosphate binder for the treatment of hyperphosphatemia","volume":"42","author":"Joy","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2025.01.038_bib25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1523-1755.1999.00240.x","article-title":"RenaGel\u00ae, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone","volume":"55","author":"Slatopolsky","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2025.01.038_bib26","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/ki.2014.58","article-title":"A\u00a0phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients","volume":"86","author":"Floege","year":"2014","journal-title":"Kidney Int"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024925000634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024925000634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:48:33Z","timestamp":1778892513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024925000634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2468024925000634"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2025.01.038","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Pan-Inhibitor of Phosphate Transporters AP306 in Hemodialysis Patients","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2025.01.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}